Identification of the PTPN22 functional variant R620W as susceptibility genetic factor for giant cell arteritis

Annals of the Rheumatic Diseases

Volumn 72, Issue 11, 2013, Pages 1882-1886

  Serrano, A ^a   Marquez A ^a   Mackie, S L ^b   Carmona, F D ^a   Solans, R ^c   Miranda Filloy, J A ^d   Hernandez Rodriguez J ^e   Cid, M C ^e   Castaneda S ^f   Morado, I C ^g   Narvaez J ^h   Blanco, R ⁱ   Sopena B ^j   Garcia Villanueva M J ^k   Monfort, J ^l   Ortego Centeno, N ^m   Unzurrunzaga, A ⁿ   Mari Alfonso B ^o   Sanchez Martin J ^p   De Miguel, E ^q   Magro, C ^m   Raya, E ^m   Braun, N ^r   Latus, J ^r   Molberg, O ^s,t   Lie, B A ^s,t   Moosig, F ^u   Witte, T ^v   Morgan, A W ^b   Gonzalez Gay M A ⁱ   Martin J ^a   more..

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL XERAL CALDE   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^g HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^h HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

ⁱ HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^j Complejo Hospitalario Universitario ^*  (Spain)

^k HOSPITAL RAMÓN Y CAJAL   (Spain)

^l HOSPITAL DEL MAR   (Spain)

^m HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

ⁿ HOSPITAL DE GALDAKAO   (Spain)

^o PARC TAULÍ HOSPITAL UNIVERSITARI   (Spain)

^p HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^q HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^r ROBERT BOSCH HOSPITAL   (Germany)

^s OSLO UNIVERSITY HOSPITAL   (Norway)

^t UNIVERSITY OF OSLO   (Norway)

^u UNIVERSITY OF LÜBECK   (Germany)

^v HANNOVER MEDICAL SCHOOL   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; CSK GENE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GERMANY; GIANT CELL ARTERITIS; HUMAN; MAJOR CLINICAL STUDY; NORWAY; PHENOTYPE; PRIORITY JOURNAL; PTPN22 GENE; REAL TIME POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; UNITED KINGDOM;

GENE POLYMORPHISM; GIANT CELL ARTERITIS; POLYMYALGIA RHEUMATICA;

CASE-CONTROL STUDIES; COHORT STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GIANT CELL ARTERITIS; HUMANS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; REAL-TIME POLYMERASE CHAIN REACTION; SRC-FAMILY KINASES;

EID: 84885174057     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203641     Document Type: Article

References (20)

1. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 2009;61:1454-61.
2. Ly KH, Regent A, Tamby MC, et al. Pathogenesis of giant cell arteritis: More than just an inflammatory condition? Autoimmun Rev 2010;9:635-45.
3. Deng J, Younge BR, Olshen RA, et al. Th17 and Th1 T-cell responses in giant cell arteritis. Circulation 2010;121:906-15.
4. Espígol-Frigolé G, Corbera-Bellalta M, Planas-Rigol E, et al. Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis. Ann Rheum Dis 2013;72:1481-7.
5. Levinson NM, Seeliger MA, Cole PA, et al. Structural basis for the recognition of c-Src by its inactivator Csk. Cell 2008;134:124-34.
6. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004;36:337-8.
7. Orozco G, Sanchez E, Gonzalez-Gay MA, et al. Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 2005;52:219-24.
8. Diaz-Gallo LM, Gourh P, Broen J, et al. Analysis of the influence of PTPN22 gene polymorphisms in systemic sclerosis. Ann Rheum Dis 2011;70:454-62.
9. Rodriguez-Rodriguez L, Taib WR, Topless R, et al. The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthritis Rheum 2011;63:365-72.
10. Manjarrez-Orduno N, Marasco E, Chung SA, et al. CSK regulatory polymorphism is associated with systemic lupus erythematosus and influences B-cell signaling and activation. Nat Genet 2012;44:1227-30.
11. Martin JE, Broen JC, Carmona FD, et al. Identification of CSK as a systemic sclerosis genetic risk factor through Genome Wide Association Study follow-up. Hum Mol Genet 2012;21:2825-35.
12. Vang T, Congia M, Macis MD, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005;37:1317-19.
13. Zhang J, Zahir N, Jiang Q, et al. The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet 2011;43:902-7.
14. Huffmeier U, Steffens M, Burkhardt H, et al. Evidence for susceptibility determinant(s) to psoriasis vulgaris in or near PTPN22 in German patients. J Med Genet 2006;43: 517-22.
15. Morgan AW, Thomson W, Martin SG, et al. Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population. Arthritis Rheum 2009;60:2565-76.
16. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
17. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995;57:289-300.
18. Baranathan V, Stanford MR, Vaughan RW, et al. The association of the PTPN22 620W polymorphism with Behcet's disease. Ann Rheum Dis 2007;66:1531-3.
19. Martorana D, Maritati F, Malerba G, et al. PTPN22 R620W polymorphism in the ANCA-associated vasculitides. Rheumatology (Oxford) 2012;51:805-12.
20. Gonzalez-Gay MA, Oliver J, Orozco G, et al. Lack of association of a functional single nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with susceptibility to biopsy-proven giant cell arteritis. J Rheumatol 2005;32:1510-12.